AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 228 filers reported holding AXSOME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.64 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,069,317 | +34.7% | 15,300 | +38.5% | 0.00% | 0.0% |
| Q2 2023 | $794,053 | +29.4% | 11,050 | +11.1% | 0.00% | +100.0% |
| Q1 2023 | $613,716 | -15.4% | 9,950 | +5.9% | 0.00% | -50.0% |
| Q4 2022 | $725,022 | +87.8% | 9,400 | +8.7% | 0.00% | +100.0% |
| Q3 2022 | $386,000 | -11.1% | 8,650 | -23.6% | 0.00% | 0.0% |
| Q2 2022 | $434,000 | -7.5% | 11,320 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $469,000 | +9.6% | 11,320 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $428,000 | -45.3% | 11,320 | -2.4% | 0.00% | -50.0% |
| Q2 2021 | $782,000 | -23.6% | 11,597 | -35.9% | 0.00% | 0.0% |
| Q1 2021 | $1,024,000 | -30.5% | 18,082 | 0.0% | 0.00% | -33.3% |
| Q4 2020 | $1,473,000 | +14.4% | 18,082 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $1,288,000 | +115.7% | 18,082 | +149.2% | 0.00% | +50.0% |
| Q2 2020 | $597,000 | +39.8% | 7,256 | 0.0% | 0.00% | +100.0% |
| Q1 2020 | $427,000 | – | 7,256 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,132,645 | $37,332,000 | 32.86% |
| MORGAN JESS S & CO INC | 113,430 | $3,739,000 | 2.47% |
| Fairmount Funds Management LLC | 187,598 | $6,183,000 | 2.25% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 1,423,653 | $46,924,000 | 1.43% |
| WMS Partners, LLC | 250,000 | $8,240,000 | 1.21% |
| Beck Bode, LLC | 102,127 | $3,366,000 | 0.94% |
| RTW INVESTMENTS, LP | 1,616,497 | $53,280,000 | 0.80% |
| MPM BioImpact LLC | 110,155 | $3,631,000 | 0.56% |
| Endurant Capital Management LP | 52,048 | $1,716,000 | 0.39% |
| Bellevue Group AG | 752,945 | $24,817,000 | 0.25% |